0.801 0.002 (0.25%) 06-28 17:35 |
|
Open: | 0.814 |
High: | 0.829 |
Low: | 0.790 |
Pre. close: | 0.799 |
Volume: | 27,494 |
Avg. volume: | 215,196 |
MA (50): | 0.869 |
MA (200): | 0.747 |
Year high: | 1.479 |
Year low: | 0.285 |
Market cap: | 49(M) |
EPS: | -0.01 |
PE ratio: | -80.1 |
SELL | BUY |
HeikinAshi: | |
Kaufmans AMA: | |
Chandelier (20): | |
MA (5): | |
MA (50): | |
MACD (26,12,9): | |
Slow KDJ (14,3): | |
RSI (14): | |
CCI (20): |
Thu, 27 Jun 2024
Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market size is set to grow by USD 2.24 billion from 2024-2028, Growing geriatric population boost the market, Technavio - PR Newswire
Fri, 23 Jun 2023
ERYTECH announces the approval of the merger with Pherecydes and reports the results of the Combined Shareholder’s Meeting held on June 23, 2023 - Yahoo Finance
Fri, 10 Mar 2023
Diffuse large B-cell lymphoma (DLBCL) therapeutics market size to increase by USD 2,061.88 million between 2022 and 2027; Growth driven by increasing approval of therapeutics - Technavio - PR Newswire
Thu, 16 Feb 2023
Erytech and Pherecydes to merge - The Pharma Letter
Mon, 25 Apr 2022
ERYTECH Pharma (ERYP.Q) has a GRASPA® on ALL, shares up +70% - Equity.Guru
Mon, 25 Apr 2022
ERYTECH Sells U.S. Manufacturing Facility and Enters Long-Term Supply Agreement with Catalent - GlobeNewswire
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.